New Saridon Tablet (Propyphenazone, Paracetamol & Caffeine)

New Saridon Tablet is a high-potency pharmacological intervention containing a unique triple-action formula specifically engineered for the clinical management of headaches, migraines, and systemic pain. Utilizing a unique “Synergistic-Analgesic” delivery system, this formulation works by concurrently modulating the organized inhibition of prostaglandin synthesis and reinforcing the structural integrity of the central nervous system response. By neutralizing the biochemical triggers of pain perception and facilitating the organized reduction of localized inflammation through a stabilized molecular complex, Saridon effectively promotes a significant increase in pain-free duration and a reduction in metabolic dullness. This targeted biochemical action provides a decisive therapeutic response by reinforcing the structural uniformity of the neurological matrix while promoting a stable, physiological recovery from acute stressors.

Key Features

Specifically formulated with a synergistic blend to target the primary pathways of the pain-signaling system.
Clinically recognized for its role in facilitating the natural optimization of onset time, providing rapid systemic relief.
Specifically engineered to reach therapeutic levels within the plasma, ensuring a robust defense against localized inflammatory markers.
Acts as a functional catalyst to stabilize the neurovascular environment and support the reduction of headache-related fatigue.
Formulated to address systemic fatigue caused by various physiological, nutritional, and environmental stress factors through a stabilized tablet matrix.

Key Ingredients

Propyphenazone (150mg)
Paracetamol (250mg)
Caffeine (50mg)
Corn Starch & Talc
Magnesium Stearate

Precautions

This is a high-potency pharmacological intervention. Consult with a specialist prior to use to ensure a formal understanding of your baseline physiological state.
Inform your physician if you have a history of impaired liver or kidney function before administration.
Discontinue use immediately if persistent localized cutaneous eruptions, severe gastrointestinal upset, or allergic reactions occur.
Avoid the concurrent use of alcohol or other paracetamol-containing products to prevent potential systemic toxicity.
Consult a healthcare provider before administration during pregnancy or lactation to ensure the physiological safety of the restoration cycle.
Keep the pack tightly sealed and store in a cool, dry place (below 25°C). Protect from moisture and direct light to maintain the molecular stability of the active constituents.

How to Use

The tablet should be swallowed whole with a glass of water. Do not crush or chew to ensure the intended systemic delivery.
Typically, one tablet constitutes the standard therapeutic dose for the restoration of physiological comfort. Do not exceed 3 tablets in a 24-hour period.
For optimal clinical results, administration should occur at the first signs of discomfort as part of your primary wellness regimen.
Ensure the oral cavity is ready for the intake of active agents. Maintain adequate systemic hydration to support the intended physiological response.
Use as a standalone treatment for acute symptoms. Allow a minimum interval of 4 to 6 hours between subsequent administrations if required.
Maintain use only as dictated by clinical requirements to document improvements in physiological markers and the restoration of systemic health.

Legal Disclaimer: New Saridon Tablet is a specialized pharmacological product. Individual results vary based on the patient’s baseline physiological state and response. This product is for use under professional guidance only. This information is for educational purposes and is not a substitute for professional medical consultation or a formal clinical diagnosis.